Healthcare focus Tullis Health Investors specializes exclusively in healthcare investments with a long-standing track record since 1986, indicating strong domain expertise and potential partnerships with portfolio companies seeking strategic guidance, capital, or exits in the healthcare sector.

EV/PE activity With a revenue range of $25M-$50M and a management of three North America–focused funds, Tullis presents opportunities for growth-stage healthcare companies seeking growth equity, buyouts, or co-investment options aligned with venture and PE timelines.

Innovation pipeline Recent launches and collaborations (AVISE CTD, Truvaga, TAC-STIM, gConcierge/gCDirect, U.S. e-commerce portal) show appetite for commercialization, digital health, and direct-to-consumer wellness, suggesting partnerships with tech-enabled health brands, medical devices, and telehealth platforms.

Strategic partnerships Active collaboration history with Air Force Research Laboratory and Teijin, plus licensing and direct-to-consumer channels, signals opportunities for co-development, strategic licensing, and access to government or multinational distribution networks.

Go-to-market enablement Investments in physician prescriber programs and online stores (gConcierge, gCDirect, telehealth integration) indicate a readiness to back portfolio companies with go-to-market acceleration, channel development, and digital sales platforms in healthcare.